Sign in

CIK 0001628171

  • Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472029180
Phone
+1 650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-17 Wei Lin Chief Medical Officer Sale −5,589 $37.39 $209K 70,851
2024-06-03 GOLDSMITH MARK A See Remarks Option exercise 10b5-1 +7,500 $4.09 $31K 329,822
2024-06-03 GOLDSMITH MARK A See Remarks Sale 10b5-1 −900 $39.09 $35K 328,922
2024-06-03 GOLDSMITH MARK A See Remarks Sale 10b5-1 −5,699 $39.99 $228K 323,223
2024-06-03 GOLDSMITH MARK A See Remarks Sale 10b5-1 −901 $40.93 $37K 322,322
2024-06-03 GOLDSMITH MARK A See Remarks Option exercise · Stock Option (Right to Buy) 10b5-1 −7,500 316,229
2024-05-21 Cislini Jeff General Counsel Sale 10b5-1 −700 $38.67 $27K 53,674
2024-05-21 Cislini Jeff General Counsel Sale 10b5-1 −800 $39.51 $32K 52,874
2024-05-03 Anders Jack Chief Financial Officer Option exercise 10b5-1 +10,000 $2.68 $27K 111,959
2024-05-03 Anders Jack Chief Financial Officer Sale 10b5-1 −10,000 $40.03 $400K 101,959
2024-05-03 Anders Jack Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 12,814
2024-04-10 GOLDSMITH MARK A See Remarks Sale 10b5-1 −7,500 $35.48 $266K 452,879
2024-04-10 GOLDSMITH MARK A See Remarks Sale 10b5-1 −5,000 $35.33 $177K 30,424
2024-04-10 GOLDSMITH MARK A See Remarks Sale 10b5-1 −5,000 $35.34 $177K 30,424
2024-04-10 Patel Sushil Director Option exercise 10b5-1 +2,155 $16.80 $36K 17,855
2024-04-10 Patel Sushil Director Sale 10b5-1 −2,155 $37.00 $80K 15,700
2024-04-10 Patel Sushil Director Option exercise · Stock Option (Right to Buy) 10b5-1 −2,155 34,645
2024-03-27 Cislini Jeff General Counsel Sale 10b5-1 −700 $30.38 $21K 55,174
2024-03-27 Cislini Jeff General Counsel Sale 10b5-1 −800 $31.52 $25K 54,374
2024-03-18 Cislini Jeff General Counsel Sale 10b5-1 −1,252 $31.58 $40K 55,874

Page 26 of 29 · 569 trades